Skip to main content

Endometrial Cancer and HNPCC

Lynch Syndrome: HNPCC

There are many reasons to wonder about your risk of colorectal or endometrial cancer - your environment, your diet, your family history. As many as 150,000 new cases of colorectal cancer and over 40,000 cases of endometrial cancer are diagnosed each year.

While the majority of colorectal and endometrial cancers are sporadic, or not caused by inherited risk factors, research has shown that up to ten percent of these cases are due to inherited cancer syndromes. One of these inherited syndromes is known as hereditary nonpolyposis colorectal cancer (HNPCC). Individuals with HNPCC have up to an 80 percent risk of colorectal cancer and up to a 71 percent risk of endometrial cancer by age 70. This is a large risk compared to the general population's risk, which is just two percent for colorectal cancer and 1.5 percent for endometrial cancer.

Additionally, people with HNPCC may have more than one type of cancer. These cancers may be diagnosed at the same or at different times. Along with colorectal and endometrial cancer, other HNPCC-related cancers include ovarian, stomach, kidney/urinary tract, brain, biliary tract, pancreas, small bowel, and sebaceous adenomas. It is important to check your family history for these cancers in addition to colorectal and/or endometrial cancers.

Inherited Risk FactorsMany individuals are unaware of their inherited risk. Whether or not you've had cancer yourself, a family history of early onset colorectal and/or endometrial cancer, or other HNPCC-related cancers at any age, is suspicious for inherited colorectal cancer.

What do we mean by inherited colorectal cancer?

We're all born with two copies of about 30,000 different genes, one copy of each gene from our mother and the other from our father. Three genes in particular, MLH1, MSH2 and MSH6 are responsible for the majority of HNPCC. We all have these genes. When functioning normally, these genes work to prevent certain cancers. But in some cases, we can inherit a mutation in one of these genes from either parent. This mutation interferes with the normal activity of the gene, making us more susceptible to colorectal, endometrial and other types of cancer. It is important to remember that although cancer risks are increased in HNPCC, they are not 100%-therefore, not all people with HNPCC will develop cancer.

If a person has an HNPCC mutation, their parents, children, brothers and sisters may also have the same mutation. Genetic testing is the only way to accurately identify individuals who carry mutations in these genes. If genetic testing leads to a diagnosis of HNPCC in an individual, it is very important for them to share their test results with family members. hare their test results with family members.

» Reducing the Risk of Colorectal Cancer: HNPCC

Comments

Popular posts from this blog

Get the Facts About Genetic Colon Cancer

Get the Facts: http://genefacts.org Lynch syndrome is a cancer predisposition syndrome caused by inherited mutations in genes responsible for correcting DNA replication errors. Individuals with Lynch syndrome have a greatly increased risk for colorectal, endometrial, and stomach cancers, and a moderately increased risk for other cancers. Key Points 1-3% of colon cancers attributable to Lynch syndrome Dominant inheritance with reduced penetrance (not all patients with mutations will manifest disease) Diagnosis based on clinical and family history, tumor pathology and/or genetic testing Screening and prophylactic surgeries effective in reducing some, but not all cancer risks Mutations in any of several genes can cause the syndrome

Cancer Survivors

Just read a story about one woman's cancer experience. I bet everyone has a story about what goes through your mind when you are told you have cancer. Her thought were about her stunned family members, one crying and the other in shock. I bet there are quite a few stories that could be qualitatively studied. Those experiences could help nurses better help patients during this time.

My Publication, "Hereditary non-polyposis colon cancer: change the name to protect the innocent." Cited in World Journal of Gastroenterology

Estradiol agonists inhibit human LoVo colorectal-cancer cell proliferation and migration t... Hsi-Hsien Hsu, Wei-Wen Kuo, Da-Tong Ju... World journal of gastroenterology : WJG 11/2014 20(44):16665-73. World Journal of Gastroenterology : WJG 11/2014; 20(44):16665-73. DOI: 10.3748/wjg.v20.i44.16665 Source: PubMed ABSTRACT To investigate the effects of 17β-estradiol via estrogen receptors (ER) or direct administration of ER agonists on human colorectal cancer. LoVo cells were established from the Bioresource Collection and Research Center and cultured in phenol red-free DMEM (Sigma, United States). To investigate the effects of E2 and/or ER selective agonists on cellular proliferation, LoVo colorectal cells were treated with E2 or ER-selective agonists for 24 h and 48 h and subjected to the MTT (Sigma) assay to find the concentration. And investigate the effects of E2 and/or ER selective agonists on cell used western immunoblotting to find out the diver...